Is It Too Late to Buy Viatris Stock?
If you're a fan of stable healthcare companies that have the potential to pay you ever-rising dividends until the cows come home, Viatris (NASDAQ: VTRS) might well become a dream stock. Though the generic drug manufacturer hasn't actually paid its dividend for a full year or increased it as of yet, there's already some evidence that it's on track to be a winner.
And with those positive signals comes a lot of attention from investors, many of whom are concerned that the company's potential future success is overblown or that it has already pushed the stock's valuation to unsustainable levels. Those concerns are valid, but I tend to disagree with them, and here's why.
Image source: Getty Images
Source Fool.com
